|
Market Closed -
Hong Kong S.E.
16:08:36 14/08/2026 HKT
|
5-day change | 1st Jan Change | ||
| 1.040 HKD | -3.70% |
|
-5.45% | +30.00% |
| 08-03 | Fusen Pharmaceutical Company Limited Selected in National Centralised Medicines Procurement in China | CI |
| 06-26 | Fusen Pharma Gets Marketing Nod for Influenza Drug in China | MT |
| Market Cap | 661M 769M 97.98M 84.62M 79.52M 72.32M 136M 9.37B 138M 932M 364M 4.69B 368M 360M 15.59B | P/E 2024 |
-2.95x | P/E 2025 | -45.1x |
|---|---|---|---|---|---|
| Enterprise Value | 883M 1.03B 131M 113M 106M 96.61M 182M 12.52B 185M 1.24B 487M 6.27B 491M 481M 20.83B | EV / Sales 2024 |
2.83x | EV / Sales 2025 | 2.76x |
| Free-Float |
26.11% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | -3.70% | ||
| 1 week | -5.45% | ||
| Current month | +2.97% | ||
| 1 month | +2.97% | ||
| 6 months | +11.83% | ||
| Current year | +30.00% |
| 1 week | 0.98 |  | 1.08 |
| 1 month | 0.98 | | 1.2 |
| Current year | 0.68 | | 1.44 |
| 1 year | 0.32 | | 1.75 |
| 3 years | 0.24 | | 1.75 |
| 5 years | 0.24 | | 3.48 |
| 10 years | 0.24 | | 20 |
| Manager | Title | Age | Since |
|---|---|---|---|
Zhen Li
DFI | Director of Finance/CFO | 48 | 18/04/2019 |
Zhi Ming Cao
IRC | Investor Relations Contact | 40 | 18/01/2013 |
Yuk Hong Yeung
SEC | Corporate Secretary | 36 | 30/09/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Tai Sheng Hou
BRD | Director/Board Member | 63 | 07/04/2017 |
Yong Sheng Chi
BRD | Director/Board Member | 64 | 07/04/2017 |
Qing Fen Meng
BRD | Director/Board Member | 61 | 07/04/2017 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 19/4/24 | Other | Chairman | 650,000 | 0.0867% | ||
| 18/4/24 | Other | Chairman | 240,000 | 0.0320% | ||
| 18/4/24 | Other | Chairman | 240,000 | 0.0320% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -3.70% | -5.45% | +192.96% | -28.28% | 97.98M | |
| -0.10% | -0.77% | +17.58% | +70.16% | 48.43B | |
| -3.26% | -5.31% | +52.47% | +114.13% | 39.72B | |
| -0.60% | -0.94% | -7.29% | +17.35% | 12.25B | |
| -2.75% | +1.88% | +14.81% | +76.92% | 11.84B | |
| -0.58% | -0.77% | +29.90% | +135.00% | 9.06B | |
| +1.56% | +5.52% | +23.69% | +41.38% | 7.57B | |
| +0.52% | +2.08% | +42.23% | -13.42% | 7.18B | |
| -0.07% | +1.72% | +13.39% | +190.65% | 6.84B | |
| -2.51% | -3.14% | -30.53% | +23.54% | 5.77B | |
| Average | -1.15% | +1.04% | +34.92% | +62.74% | 14.88B | |
| Weighted average by Cap. | -1.21% | +1.00% | +24.94% | +80.21% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 326M 379M 48.34M 41.75M 39.23M 35.68M 67.08M 4.62B 68.19M 460M 180M 2.31B 181M 178M 7.69B | 273M 318M 40.53M 35.01M 32.9M 29.92M 56.25M 3.88B 57.17M 385M 151M 1.94B 152M 149M 6.45B |
| Net income | -189M -220M -27.99M -24.18M -22.72M -20.66M -38.84M -2.68B -39.48M -266M -104M -1.34B -105M -103M -4.45B | -11.78M -13.71M -1.75M -1.51M -1.42M -1.29M -2.42M -167M -2.46M -16.62M -6.5M -83.66M -6.56M -6.42M -278M |
| Net Debt | 367M 427M 54.45M 47.03M 44.19M 40.19M 75.56M 5.21B 76.81M 518M 202M 2.61B 204M 200M 8.66B | 222M 258M 32.91M 28.43M 26.71M 24.29M 45.68M 3.15B 46.43M 313M 122M 1.58B 124M 121M 5.24B |
Employees
1,005
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 14/08/26 | HK$1.040 | -3.70% | 66,000 |
| 13/08/26 | HK$1.080 | 0.00% | 6,000 |
| 12/08/26 | HK$1.080 | +1.89% | 60,000 |
| 11/08/26 | HK$1.060 | 0.00% | 4,000 |
| 10/08/26 | HK$1.060 | -3.64% | 77,000 |
- Stock Market
- Stocks
- 1652 Stock
Select your edition
All financial news and data tailored to specific country editions
